about
Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapyEffect of substrate residues on the P2' preference of retroviral proteinasesMolecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases.Local and spatial factors determining HIV-1 protease substrate recognition.Identification of broad-based HIV-1 protease inhibitors from combinatorial librariesFeline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV.Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cellsPredicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method.Defective hydrophobic sliding mechanism and active site expansion in HIV-1 protease drug resistant variant Gly48Thr/Leu89Met: mechanisms for the loss of saquinavir binding potencyMolecular analysis of the feline immunodeficiency virus protease: generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases.Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and EIAVReal-time measurements of dark substrate catalysisDrug resistance mutations can effect dimer stability of HIV-1 protease at neutral pH.Molecular mechanisms of FIV infection.Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavirAmino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site.Comparative studies on retroviral proteases: substrate specificity.Characterization of the protease of a fish retrovirus, walleye dermal sarcoma virus.Effect of internal cleavage site mutations in human immunodeficiency virus type 1 capsid protein on its structure and function.Ordered processing of the human immunodeficiency virus type 1 GagPol precursor is influenced by the context of the embedded viral proteaseMutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity.Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sitesA cleavage enzyme-cytometric bead array provides biochemical profiling of resistance mutations in HIV-1 Gag and protease.Effect of sequence polymorphism and drug resistance on two HIV-1 Gag processing sites.Expression and characterization of human foamy virus proteinase.Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease.Competitive inhibition of human immunodeficiency virus type-1 protease by the Gag-Pol transframe protein.Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase.Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus.Bacterial aspartic proteinases.Computational coevolution of antiviral drug resistance.Aspartic protease inhibitors
P2860
Q27640250-0F24FD89-325B-4ACA-AD88-BBD4134783C7Q28372993-F1ED4E22-272F-4531-BE63-FC44DA0B4BABQ30708352-B75FB5C7-4B9D-40D8-82A1-C544109C4816Q31956049-E43218FF-B7B1-447A-BF2D-387C4E6F041EQ33589171-D2271D82-35B9-4550-AECD-BECED0C718EFQ33786404-F55B494A-E6BB-4288-B006-48EBE4CFD7A0Q33953076-8913417A-7413-4505-880E-B11744512C56Q34379398-6798B361-336E-4481-BFB4-B7D76D4E2599Q35001188-50F0E350-D6BC-45E8-A88F-0BBBD3B20288Q35888615-103A4DC5-B611-467E-9F65-50D2427E7FB4Q36280729-AF20B589-A738-460B-B771-F3091591096EQ36281355-1509B672-0390-4852-921D-31DDC949516CQ36281663-9AA7D05A-B0C1-47F2-AF4D-2712F2C03CB4Q36692802-B8D158BF-EC64-480A-A07F-BC2878696C88Q36841895-5E3D41A4-4FFF-47DF-9EDA-5B8100878C6DQ36933950-7D495CA7-DE5C-4A1A-8F72-98D86E783059Q38613993-08645161-1D2B-4627-AE7D-66640E759099Q39752728-2E6D4EE7-9307-4970-86AA-BA9631F44C9BQ40578149-3EA7ACC5-6893-4027-8593-60185A33E901Q41997191-12C18A1F-D4F8-479B-AE6F-D113271B5461Q42552199-BE7A9297-B474-4BE5-9DF4-A645DAA34F2EQ42702065-75CEA2FE-25C9-4A9A-99DF-D5BC1394DC22Q42872702-F04C6B6A-BE1D-4CA9-8DFD-095B130C715EQ44103766-C2EFD2AE-BAE6-48E5-9CAD-1386AD77F1BEQ44169601-761AFFAE-64A4-4990-B085-E5279FF858B5Q44854785-8222E985-5DC7-4A4B-8233-A095587E1FB7Q45748209-414894EE-5751-428A-9DDC-FB81181EF5DBQ45751051-EDD02769-0A64-4785-8E0C-B0179D9AB1F1Q45766402-F2BD6580-8DBD-47E8-B8C0-D49E478B5CB7Q48048509-8775E7CE-CDDA-477E-88B3-A36F7B834617Q52232508-598A6161-DBEC-48E4-97F3-D6A7A443F380Q57504648-83F63F75-EF9D-49AA-8870-E2D330BB9B0A
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Subsite preferences of retroviral proteinases.
@en
type
label
Subsite preferences of retroviral proteinases.
@en
prefLabel
Subsite preferences of retroviral proteinases.
@en
P2093
P1476
Subsite preferences of retroviral proteinases.
@en
P2093
P304
P356
10.1016/0076-6879(94)41068-2
P407
P577
1994-01-01T00:00:00Z